Navigation Links
Catalent Expert to Present on Enhancing Bioavailability of Poorly Absorbed Drugs at Japan Society of Drug Delivery Systems
Date:7/29/2014

Somerset, NJ (PRWEB) July 29, 2014

Catalent Pharma Solutions, the global leader in drug development solutions and advanced delivery technologies for pharmaceutical, biologic, and consumer health products, today announced that Dr. Jeff Browne, R&D Director and US Platform Leader of Pharmaceutical Softgels, will present “Enhancing the Bioavailability of Absorption-Limited Drugs with Lipid-Based Formulations using Soft Capsule Delivery Systems” at the forthcoming 30th Annual Meeting of the Japan Society of Drug Delivery Systems (30-31 July 2014, Tokyo, Japan).

Dr. Browne’s presentation, which is a luncheon seminar on Wednesday July 30th, at 12.00 noon, will provide insight into the usefulness of lipid-based formulations to enhance absorption for drugs with limited oral bioavailability, characterized by poor solubility and/or permeability. The process of preformulation studies and prototype formulation development on a placebo lipid-based formulation will be used to demonstrate the considerations necessary before highlighting the benefits of soft capsules as a delivery method for such formulations. Catalent’s non-gelatin OptiShell™ capsule technology has successfully been used to overcome incompatibilities with gelatin-based shells, and more recently, the use of film-coated soft capsules has been investigated.

Dr. Browne’s career with Catalent started in 1994 and since then, he has held a number of positions before becoming R&D Director and US Platform Leader of Pharma Softgels. These included Executive Director & Division Head of Pharmaceutical Development in Research Triangle Park, NC, and most recently Technical Director, Pharmaceutical Softgels. He is an active member of the American Association of Pharmaceutical Scientists (AAPS) and has served on several of their Focus Group committees. He is a frequent presenter at both regional and national AAPS meetings. Dr. Browne received his Ph.D. from Purdue University in Industrial and Physical Pharmacy.

For more information on the Japan Society of Drug Delivery Systems, visit: http://www.procomu.jp/DDS2014/index.html, and to arrange a meeting with Dr. Browne, contact Richard Kerns at richard(at)nepr(dot)eu.

About Catalent:

Catalent Pharma Solutions is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance, and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,500 people, including over 1,000 scientists, at nearly 30 facilities across 5 continents, and in Fiscal 2013, generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Read the full story at http://www.prweb.com/releases/2014/07/prweb12054220.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pure MHC and Catalent Sign RL21 Anti-Cancer Development Deal
2. Catalent’s Clinical Trial Supply Facility in Shanghai, China Opens for Business
3. Catalent Creates New Advanced Delivery Technologies Business Unit
4. Oxnard Dental Implant Experts Warn of Infections Around Dental Implants
5. Lift U.S. Ban on Blood Donations by Gay Men, Experts Say
6. Fitness Marketing Expert Bedros Keuilian’s New Post Shares Why People Still Need Personal Trainers in the Age of Google
7. Mindy Berkson, Infertility Expert and Founder, Lotus Blossom Consulting LLC: Leading the Pathway to Parenthood
8. New Video Release: Jason Feruggia’s Interview with Personal Trainer Marketing Expert Bedros Keuilian
9. Psoriatic arthritis patients need better screening, warns panel of experts
10. Willem de Liefde, Author and Management Expert, Releases New Guide for Understanding Friends, Family, Co-Workers and Ourselves
11. PoisonEXPERT™ from ExPub Now Available
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... “The Financial Favor of God; ... Favor of God; Second Edition” is the creation of published author, Brooks Rathell. , ... opportunity to talk to you about the financial favor of God. Not only does ...
(Date:9/20/2017)... ... ... “Monique”: is the story of Monique, whose mother’s deteriorating physical condition forces the ... has owned four beauty salons and written a book regarding the author’s success in ... , “The doctor’s office was only three blocks away, and she could walk it, ...
(Date:9/19/2017)... ... September 19, 2017 , ... Only a few physicians were selected to receive ... Ross A. Clevens, MD, FACS . The founder and medical director of Clevens ... who trained at Yale, Harvard and the University of Michigan. He has served patients ...
(Date:9/19/2017)... ... September 19, 2017 , ... PAPA Healthcare, Inc. announced ... called, “PAPA Healthcare helps fill gaps, provide essential insights, and improve productivity.” ... operations by leveraging PAPA Healthcare’s post-acute productivity and analytics solutions. , St. Vincent’s ...
(Date:9/19/2017)... ... September 19, 2017 , ... Peter Chandonait, ... President’s Malaria Initiative (PMI) Africa Indoor Residual Spraying (AIRS) Project , has ... , The Innovation to Action Award, a USAID Catalyst Award, recognizes USAID staff ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... N.J. , Sept. 5, 2017  Getinge, ... has created a vibrant charitable donation program -- ... and support congenital heart defect research by The ... providers and the general public are encouraged to ... and submit the completed artwork to the gallery ...
(Date:9/1/2017)... Michael Penna , President and CEO ... for growth in his response to the July 13, ... seeking a buyer for eMDs. Penna,s company, Complete HealthCare ... Value Added Reseller and national leader in the independent ... "As the healthcare market continues to dictate consolidation, healthcare ...
Breaking Medicine Technology: